Jonathan Chee

1.5k total citations
36 papers, 1.1k citations indexed

About

Jonathan Chee is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Jonathan Chee has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 20 papers in Oncology and 11 papers in Genetics. Recurrent topics in Jonathan Chee's work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (13 papers) and Diabetes and associated disorders (11 papers). Jonathan Chee is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (13 papers) and Diabetes and associated disorders (11 papers). Jonathan Chee collaborates with scholars based in Australia, United States and Canada. Jonathan Chee's co-authors include Thomas W. H. Kay, Balasubramanian Krishnamurthy, Helen E. Thomas, Kate L. Graham, John D. MacMicking, Gaurang Jhala, Claudia Selck, Anna K. Nowak, Prerak Trivedi and Richard Lake and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Immunology.

In The Last Decade

Jonathan Chee

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Chee Australia 16 573 332 305 222 161 36 1.1k
Jared E. Lopes United States 9 1.6k 2.7× 378 1.1× 357 1.2× 204 0.9× 70 0.4× 14 2.1k
Gady Cojocaru United States 10 412 0.7× 161 0.5× 725 2.4× 151 0.7× 133 0.8× 22 1.3k
Robyn M. Sutherland Australia 26 1.2k 2.2× 380 1.1× 460 1.5× 431 1.9× 343 2.1× 58 2.0k
Michael Merger Germany 12 323 0.6× 178 0.5× 269 0.9× 130 0.6× 201 1.2× 21 959
Michail Schizas United States 16 623 1.1× 361 1.1× 531 1.7× 133 0.6× 142 0.9× 17 1.4k
Anna Vossenkämper United Kingdom 20 494 0.9× 113 0.3× 473 1.6× 206 0.9× 123 0.8× 28 1.2k
Yasushi Kobayashi Japan 12 675 1.2× 124 0.4× 195 0.6× 89 0.4× 95 0.6× 13 1.0k
Lorena Lerner United States 13 212 0.4× 262 0.8× 520 1.7× 116 0.5× 65 0.4× 23 1.2k
Hiroyoshi Hattori Japan 17 325 0.6× 310 0.9× 435 1.4× 126 0.6× 47 0.3× 39 989
Abbas Hawwari Saudi Arabia 19 636 1.1× 154 0.5× 334 1.1× 125 0.6× 39 0.2× 37 1.1k

Countries citing papers authored by Jonathan Chee

Since Specialization
Citations

This map shows the geographic impact of Jonathan Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Chee more than expected).

Fields of papers citing papers by Jonathan Chee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Chee. The network helps show where Jonathan Chee may publish in the future.

Co-authorship network of co-authors of Jonathan Chee

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Chee. A scholar is included among the top collaborators of Jonathan Chee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Chee. Jonathan Chee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elaskalani, Omar, Ben Wylie, Caitlin M. Tilsed, et al.. (2024). Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 12(9). e008568–e008568. 2 indexed citations
2.
Tilsed, Caitlin M., Wee Loong Chin, Rachael M. Zemek, et al.. (2022). CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy. Cell Reports. 41(13). 111874–111874. 8 indexed citations
3.
Jhala, Gaurang, Balasubramanian Krishnamurthy, Thomas C. Brodnicki, et al.. (2022). Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse. Cell Reports. 39(4). 110747–110747. 5 indexed citations
4.
Tilsed, Caitlin M., Scott Fisher, Louis Boon, et al.. (2022). Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations. Frontiers in Immunology. 13. 872295–872295. 12 indexed citations
5.
Dolcetti, Riccardo, et al.. (2021). Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy — Methods & Clinical Development. 21. 592–606. 23 indexed citations
6.
Fear, Vanessa S., Catherine A. Forbes, Scott Fisher, et al.. (2021). Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used. Cancer Immunology Immunotherapy. 70(11). 3249–3258. 28 indexed citations
7.
Lake, Richard, et al.. (2021). Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?. Frontiers in Oncology. 11. 672747–672747. 13 indexed citations
8.
Li, Shamin, Yannick Simoni, Austin M. Gabel, et al.. (2021). Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proceedings of the National Academy of Sciences. 118(30). 40 indexed citations
9.
Goh, Siting, Caitlin M. Tilsed, Scott Fisher, et al.. (2020). Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Frontiers in Immunology. 11. 584423–584423. 48 indexed citations
10.
Watson, Mark, Timo Lassmann, Robert A. Holt, et al.. (2020). Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses. Frontiers in Immunology. 11. 587014–587014. 59 indexed citations
11.
Fear, Vanessa S., Catherine A. Forbes, Jonathan Chee, et al.. (2019). Neo-antigen specific T cell responses indicate the presence of metastases before imaging. Scientific Reports. 9(1). 14640–14640. 3 indexed citations
12.
Trivedi, Prerak, Stacey Fynch, Jonathan Chee, et al.. (2019). Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice. Cell Death Discovery. 5(1). 136–136. 6 indexed citations
13.
Chee, Jonathan, Mark Watson, Abha Chopra, et al.. (2018). Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors. BMC Research Notes. 11(1). 864–864. 13 indexed citations
14.
Kim, Bae-Hoon, Jonathan Chee, Clinton J. Bradfield, et al.. (2016). Interferon-induced guanylate-binding proteins in inflammasome activation and host defense. Nature Immunology. 17(5). 481–489. 116 indexed citations
15.
Krishnamurthy, Balasubramanian, et al.. (2016). Analysis of antigen specific T cells in diabetes – Lessons from pre-clinical studies and early clinical trials. Journal of Autoimmunity. 71. 35–43. 19 indexed citations
16.
Chee, Jonathan, B. W. Robinson, Robert A. Holt, & Jenette Creaney. (2016). Immunotherapy for Lung Malignancies. CHEST Journal. 151(4). 891–897. 9 indexed citations
17.
Marty-Roix, Robyn, Gregory I. Vladimer, Kimberly Pouliot, et al.. (2015). Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants. Journal of Biological Chemistry. 291(3). 1123–1136. 148 indexed citations
18.
Krishnamurthy, Balasubramanian, Jonathan Chee, Gaurang Jhala, et al.. (2015). BIM Deficiency Protects NOD Mice From Diabetes by Diverting Thymocytes to Regulatory T Cells. Diabetes. 64(9). 3229–3238. 11 indexed citations
19.
Graham, Kate L., Robyn M. Sutherland, Stuart I. Mannering, et al.. (2012). Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease. The Review of Diabetic Studies. 9(4). 148–168. 54 indexed citations
20.
Thomas, Helen E., Kate L. Graham, Jonathan Chee, et al.. (2012). Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes. Annals of the New York Academy of Sciences. 1283(1). 81–86. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared E. Lopes Breakdown of academic impact, for papers by Gady Cojocaru Breakdown of academic impact, for papers by Robyn M. Sutherland Breakdown of academic impact, for papers by Michael Merger Breakdown of academic impact, for papers by Michail Schizas Breakdown of academic impact, for papers by Anna Vossenkämper Breakdown of academic impact, for papers by Yasushi Kobayashi Breakdown of academic impact, for papers by Lorena Lerner Breakdown of academic impact, for papers by Hiroyoshi Hattori Breakdown of academic impact, for papers by Abbas Hawwari
Rankless by CCL
2026